 ROCKVILLE, Md., Jan. 06, 2021 GLOBE NEWSWIRE -- Supernus Pharmaceuticals, Inc. Nasdaq: SUPN, a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system CNS diseases, today announced that the Companys management will present at the J.P. Morgan 39th Annual Healthcare Conference on Thursday, January 14, 2021, at 9:10 a.m. ET, and will be available for virtual investor meetings. 